New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

Some researchers argue that the roles of social environment and personal choice have to be considered in order to make progress in treating people addicted to drugs. By Jan Hoffman The message ...

TAMPA, FL - March 09, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has published a new educational resource ...

FORT LAUDERDALE, FL - March 06, 2026 - PRESSADVANTAGE - Grace Point Treatment Center has published a new educational ...

Social rank regulates methamphetamine-seeking behavior by modulating the mesocortical and mesolimbic dopamine pathways, and winning experiences can remodel these circuits to suppress drug-seeking. In ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...

A diabetes and obesity medication shows potential to reduce alcohol cravings and relapse in early animal studies.

A class of drugs commonly used to treat movement disorders like Parkinson’s disease and restless leg syndrome is pushing people into risky sexual behavior. Patients taking dopamine agonists say the ...